Healthy Skepticism Library item: 626
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Gilbert D, Chetley A.
New trends in drug promotion
Consumer Policy Review 1996; 63:(5):162-167
Abstract:
As the National Health Service (NHS) moves towards evidence-based medicine and more rational prescribing, drug companies are seeking new ways to promote their products. They target the NHS by sponsoring conferences, publications and continuing education. Of equal concern is the promotion to consumers through patient groups, the Internet and other forms of patient information. This is defended as promoting consumer choice. But by redefining illness and “selling†the disease, they create new markets for themselves. A thorough review of self-regulation is required.
Keywords:
*analysis
United Kingdom
National Health Service
NHS
sponsored symposia & conferences
Internet
regulation of promotion
general public and consumers
patient groups
patient education material
Association of the British Pharmaceutical Industry
ABPI
Code of Practice (UK)
press conferences and releases
conflict of interest
quality of information
EVALUATION OF PROMOTION: PATIENT HANDOUTS
PROMOTION DISGUISED: CONFERENCES AND MEETINGS
PROMOTION DISGUISED: PRESS CONFERENCES AND PRESS COVERAGE
PROMOTIONAL TECHNIQUES: INTERNET ADVERTISING
REGULATION, CODES, GUIDELINES: COMPLIANCE, SANCTIONS, STANDARDS
REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION
SPONSORSHIP: PATIENT AND CONSUMER ORGANIZATIONS
